Delaware medical journal
-
Delaware medical journal · Jan 1999
Randomized Controlled Trial Clinical TrialEffects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients.
Previous studies have shown that the Scandipharm Flutter airway clearance device has increased the ability of cystic fibrosis patients to expectorate mucus. Studies that show the effects of the Flutter on pulmonary function among the pediatric cystic fibrosis patients are limited. Thus, we embarked on a study to assess the device's effectiveness. ⋯ This study has shown no significant change in respiratory assessment parameters or pulmonary function. Further studies involving multicenter trials are warranted to evaluate the effects of the Flutter on pulmonary function.